AI & Data Analytics

Business

Cybersecurity

Data + Technology

Diversity, equity and inclusion

Financial Decision Making

Health equity

Healthcare Transformation

Interoperability & EHRs

Leadership

Management

Medical Devices

Mergers and Acquisitions

Patient Experience

Point of Care Tools

Politics

Pop Health Tech

Precision Medicine

Product Solutions

Providers in Practice

Safer Hospitals

Technology

Telehealth

Virtual Care

News

Media

Medical World News

Peer Exchange

Podcasts

Videos

Webinars

Conferences

Resources

Subscribe

About

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Chief Healthcare Executive

LinkedIn

Twitter

Spotlight

Topics

Mergers & Acquisitions

1rem

Continuing Medical Education

San Diego Lung Symposia

Martin F. Dietrich, MD, PhD; Neil A. Abrahams, MD; Shirley M. Shiller, DO, AP/CP, MGP, FACP

Pathology Implications for CEACAM5 as a Therapeutic Target in Advanced NSCLC

Beth Sandy, MSN, CRNP; Jacob Sands, MD; Stephanie McDonald, NP, FNP-BC, AOCNP

Medical Crossfire®: What Are Effective Strategies for Onco-Nurses to Improve Outcomes in Patients with Small Cell Lung Cancer?

 2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference

Timiya S. Nolan, PhD, APRN-CNP, ANP-BC; Rachel Hirschey, PHD, RN

Taking a Critical Look at Healthcare Inequity Among Patients with Cancer: What Role Do Onco-Nurses Play?

Neoadjuvant Immunotherapy in Melanoma: Where We Are, and Where We Aren’t

2024 International Symposium of Gastrointestinal Oncology (ISGIO) 

Edward B. Garon, MD, MS; Rebecca Heist, MD, MPH; Solange Peters, MD, PhD; Jacob Sands, MD

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

Ajai Chari, MD; Alfred Chung, MD; Adriana Rossi, MD

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

PER LIVER CANCER TUMOR BOARD: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today, and Tomorrow?

Balazs Halmos, MD, MS; Kristen K. Ciombor, MD, MSCI; Joyce O’Shaughnessy, MD; Daniel P. Petrylak, MD 

Community Practice Connections™: Clinical Updates from Chicago – A Focus on What Community Centers Need to Know to Move Their Solid Tumors' Practices Forward

Maurie Markman, MD; Rachel N. Grisham, MD; Bhavana Pothuri, MD

  Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

Howard I. Scher, MD; Scott T. Tagawa, MD, MS, FACP; Mary-Ellen Taplin, MD

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

Andre H. Goy, MD; Sandra M. Swain, MD, FACP, FASCO Associate Dean for Research; Carolina Bernabe Ramirez, MD; Jonathan E. Rosenberg, MD; David H. Vesole, MD, PhD, FACP Director, Myeloma Program; Isabel Preeshagul, DO, MBS  
 

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

Vivek Subbiah, MD; Brian A. Van Tine, MD, PhD

Tumor Agnostic Trials and the Reshaping of Precision Medicine in Oncology: A Focus on TSC1/2 Mutations

Community Practice Connections™: Optimize the Diagnosis and Treatment of HER2-Positive Colorectal Cancer

Annual Hematology Meeting: Preceding the 66th ASH Annual Meeting and Exposition

David Planchard, MD, PhD; Martin F. Dietrich, MD, PhD

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Benjamin P. Levy, MD; Komal Jhaveri, MD, FACP; Joshua K. Sabari, MD

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

Andrew Kuykendall, MD; Naveen Pemmaraju, MD; Barbara Mora, MD; Gabriela Hobbs, MD

Show Me the Data: How Do We Navigate the Latest Evidence on Novel Therapies, Combinations, and Clinical Trials Across MPN Care in the Context of Current Treatment Algorithms?

Joseph R. Mikhael, MD, MEd, FRCPC, FACP; Ajai Chari, MD; Caitlin Costello, MD; Krina Patel, MD, MSc

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

George M. Rodgers III, MD, PhD; Patricia A. Ford, MD; Sidharth Anand, MD, MBA

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

Towards Personalized Treatment Approaches in Soft Tissue Sarcomas

22nd Annual Winter Lung Cancer Conference®

Brendon M. Stiles, MD; Jamie E. Chaft, MD; Balazs Halmos, MD, MS

 Dialogues With the Surgeon on Integration of Systemic Therapies in Perioperative Settings for NSCLC: Looking at EGFR, ALK, IO, and Beyond…

Tanios Bekaii-Saab, MD, FACP; Aiwu Ruth He, MD, PhD; Eugene J. Koay, MD

The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape

42nd Annual Miami Breast Cancer Conference®

Heather McArthur, MD, MPH; William J. Gradishar, MD, FASCO, FACP; Jennifer Keating Litton, MD, MHCM; Debu Tripathy, MD

 The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

Nicole Lamanna, MD; William Wierda, MD, PhD; Jennifer A. Woyach, MD

Medical Crossfire®: The Experts Bridge Recent Data in Chronic Lymphocytic Leukemia With Real-World Sequencing Questions

Tanios Bekaii-Saab, MD, FACP; Richard S. Finn, MD; Aiwu Ruth He, MD, PhD; Eugene J. Koay, MD

Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma

Andre H. Goy, MD; Marco L. Davila, MD, PhD; Ajay K. Nooka, MD, MPH, FACP

Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy

Kevin Kalinsky, MD, MS; Komal Jhaveri, MD, FACP; Reshma L. Mahtani, DO; Kelly McCann, MD, PhD

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

E. Gabriela Chiorean, MD, FASCO; John L. Marshall, MD; Diana L. Hanna, MD; Syma Iqbal, MD; Heloisa P. Soares, MD, PhD Associate Professor 

  Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®

Exploring the Benefits and Risks of AI in Oncology

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

Karen M. Winkfield, MD, PhD; Narjust Florez, MD, FASCO; Gilberto de Lima Lopes Junior, MD, MBA, FASCO; Coral Olazagasti, MD; Vonetta M. Williams, MD, PhD

 Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

26th Annual International Lung Cancer Congress®

Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD

Upcoming CME Events & Activities

EVENTS

ACTIVITIES